Fredun Pharmaceuticals Limited (FREDUN.BO)
INR 667.95
(-0.42%)
INR 667.95
(-0.42%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.07 Billion INR | 19.56% |
| 2022 | 2.57 Billion INR | 37.59% |
| 2021 | 1.86 Billion INR | 15.7% |
| 2020 | 1.61 Billion INR | 14.32% |
| 2019 | 1.41 Billion INR | 34.76% |
| 2018 | 1.04 Billion INR | 32.35% |
| 2017 | 792.64 Million INR | 41.3% |
| 2016 | 560.97 Million INR | 29.86% |
| 2015 | 431.99 Million INR | 87.88% |
| 2014 | 229.93 Million INR | 30.25% |
| 2013 | 176.53 Million INR | 19.73% |
| 2012 | 147.44 Million INR | 14.97% |
| 2011 | 128.25 Million INR | 28.57% |
| 2010 | 99.75 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | 3.07 Billion INR | 10.44% |
| 2023 FY | 3.07 Billion INR | 19.56% |
| 2023 Q2 | 2.78 Billion INR | 0.0% |
| 2023 Q4 | 3.07 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 2.57 Billion INR | 37.59% |
| 2022 Q4 | 2.57 Billion INR | 0.0% |
| 2022 Q2 | 2.32 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 1.86 Billion INR | 15.7% |
| 2021 Q2 | 1.97 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.86 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 1.61 Billion INR | 14.32% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 1.43 Billion INR | 0.0% |
| 2020 Q4 | 1.61 Billion INR | 0.0% |
| 2019 Q2 | 1.26 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 1.41 Billion INR | 34.76% |
| 2019 Q4 | 1.41 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 FY | 1.04 Billion INR | 32.35% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 934.99 Million INR | 0.0% |
| 2018 Q4 | 1.04 Billion INR | 0.0% |
| 2017 Q4 | 793.04 Million INR | 0.0% |
| 2017 FY | 792.64 Million INR | 41.3% |
| 2017 Q2 | 645.74 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 496.8 Million INR | 0.0% |
| 2016 FY | 560.97 Million INR | 29.86% |
| 2016 Q4 | 560.97 Million INR | 0.0% |
| 2015 Q4 | 431.99 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q2 | 296.74 Million INR | 0.0% |
| 2015 FY | 431.99 Million INR | 87.88% |
| 2015 Q3 | - INR | -100.0% |
| 2014 FY | 229.93 Million INR | 30.25% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 200.3 Million INR | 0.0% |
| 2014 Q4 | 229.93 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q4 | 176.53 Million INR | 0.0% |
| 2013 Q2 | 159.62 Million INR | 0.0% |
| 2013 FY | 176.53 Million INR | 19.73% |
| 2012 FY | 147.44 Million INR | 14.97% |
| 2012 Q4 | 147.44 Million INR | 0.0% |
| 2011 FY | 128.25 Million INR | 28.57% |
| 2010 FY | 99.75 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ANG Lifesciences India Limited | 2.42 Billion INR | -26.878% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | -144.215% |
| Bacil Pharma Limited | 13.26 Million INR | -23095.77% |
| BDH Industries Limited | 934.11 Million INR | -229.295% |
| Beryl Drugs Limited | 174.86 Million INR | -1659.026% |
| Cian Healthcare Limited | 1.61 Billion INR | -90.847% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -2263.384% |
| Concord Drugs Limited | 588.06 Million INR | -423.071% |
| Deccan Health Care Limited | 1.08 Billion INR | -184.687% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -814.573% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -1221.671% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | -39.114% |
| Hindustan Bio Sciences Limited | 33.74 Million INR | -9015.937% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | -86.311% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -2745.847% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 21.971% |
| Panchsheel Organics Limited | 1.59 Billion INR | -93.392% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | -207.702% |
| Parnax Lab Limited | 1.88 Billion INR | -62.953% |
| Makers Laboratories Limited | 1.61 Billion INR | -90.752% |
| Medi-Caps Limited | 1.27 Billion INR | -141.662% |
| MedPlus Health Services Limited | 30.04 Billion INR | 89.763% |
| Phaarmasia Limited | 314.47 Million INR | -878.126% |
| Parmax Pharma Limited | 176.12 Million INR | -1646.469% |
| Patidar Buildcon Limited | 94.27 Million INR | -3162.751% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -608.667% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -17376.229% |
| Trident Lifeline Limited | 870.76 Million INR | -253.253% |
| Tyche Industries Limited | 1.36 Billion INR | -124.69% |
| Vivanza Biosciences Limited | 195.01 Million INR | -1477.318% |
| PRAVEG LIMITED | 3.64 Billion INR | 15.631% |
| Smruthi Organics Limited | 1.18 Billion INR | -160.257% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -1200.592% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | -8.644% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 73.243% |
| Transchem Limited | 763.18 Million INR | -303.049% |
| Trinity League India Limited | 32.38 Million INR | -9397.903% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | -115.594% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | -430.535% |
| Sunil Healthcare Limited | 1.58 Billion INR | -94.069% |
| Syschem (India) Limited | 1.64 Billion INR | -87.528% |
| Zenith Healthcare Limited | 97.41 Million INR | -3057.68% |
| Zenlabs Ethica Limited | 402.58 Million INR | -664.062% |
| Mercury Laboratories Limited | 679.57 Million INR | -352.635% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -711.29% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -724.596% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | -63.055% |
| Roopa Industries Limited | 647.82 Million INR | -374.821% |
| PANJON LTD. | 173.91 Million INR | -1668.705% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | -236.76% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -3133.664% |
| Anuh Pharma Limited | 4.45 Billion INR | 30.982% |
| Crestchem Limited | 71.44 Million INR | -4205.578% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -3418.273% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -486.854% |
| Trimurthi Limited | 73.64 Million INR | -4076.552% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | -295.183% |
| Norris Medicines Limited | 141.87 Million INR | -2068.129% |
| Veerhealth Care Limited | 281.16 Million INR | -994.005% |
| Lactose (India) Limited | 1 Billion INR | -205.343% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | -386.768% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | -22.927% |
| Gennex Laboratories Limited | 2.29 Billion INR | -33.747% |
| Denis Chem Lab Limited | 1.09 Billion INR | -181.301% |
| Colinz Laboratories Limited | 113.59 Million INR | -2607.882% |
| Godavari Drugs Limited | 1.34 Billion INR | -128.27% |
| Zenotech Laboratories Limited | 1.06 Billion INR | -189.624% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | -79.951% |
| Bharat Parenterals Limited | 5.03 Billion INR | 38.947% |
| Coral Laboratories Limited | 2.05 Billion INR | -49.552% |
| Evoq Remedies Limited | 368.61 Million INR | -734.484% |
| Kerala Ayurveda Limited | 1.4 Billion INR | -118.315% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | -330.85% |
| Natural Capsules Limited | 3.76 Billion INR | 18.306% |
| Auro Laboratories Limited | 852.67 Million INR | -260.744% |